Doniselli, Fabio M.
Ramos, João
Hilario, Amaya
Opancina, Valentina
van der Hoorn, Anouk
Castellano, Antonella
van der Molen, Aart J.
Quattrocchi, Carlo C.
Yousry, Tarek
Rovira, Àlex https://orcid.org/0000-0002-2132-6750
,
van der Molen, Aart J.
,
,
van der Hoorn, Anouk
,
,
,
Article History
Received: 2 January 2025
Revised: 25 February 2025
Accepted: 5 April 2025
First Online: 6 June 2025
Compliance with ethical standards
:
: The scientific guarantor of this publication is Dr. Rovira.
: À.R. serves/ed on scientific advisory boards for Novartis, Sanofi-Genzyme, Synthetic MR, TensorMedical, Roche, and Biogen, and has received speaker honoraria from Bayer, Sanofi-Genzyme, Merck-Serono, Teva Pharmaceutical Industries Ltd, Novartis, Roche, Bristol-Myers and Biogen. He is the CMO and co-founder of TensorMedical. F.D., J.R., A.H., and V.O. do not have any conflicts of interest to disclose. A.C. is a consultant for Genenta Science. A.v.d.H. served/ed as a medical annotation specialist for Quantitas solutions and on the global glioma education steering committee for Servier. A.J. receives consultancy fees from Guerbet as a member of the Expert Group for Gadopiclenol in the Netherlands. C.C.Q. has signed speaker contracts with Bayer Healthcare, Bracco Imaging, and Guerbet. He is co-chair of the ESMRMB-GREC Working Group, whose yearly meetings have received unconditional support from Bayer Healthcare, Bracco Imaging, GE HealthCare, and Guerbet. He is a member of the ESUR-CMSC, whose 2-yearly meetings have received support from Bayer Healthcare, Bracco Imaging, GE HealthCare, and Guerbet.
: The authors have significant statistical expertise. No complex statistical methods were necessary for this paper.
: Written informed consent was not required for this study because this is a review article.
: Institutional Review Board approval was not required because this is a review article.
: